Aggressive variants of papillary thyroid carcinoma

Head and Neck

Volumn 33, Issue 7, 2011, Pages 1052-1059

  Silver, Carl E ^a   Owen, Randall P ^b   Rodrigo, Juan P ^c,d   Rinaldo, Alessandra ^e   Devaney, Kenneth O ^f   Ferlito, Alfio ^e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e UNIVERSITY OF UDINE   (Italy)

^f Allegiance Health ^*  (United States)

Author keywords

aggressive variant papillary carcinoma; columnar cell; diffuse sclerosing insular; solid trabecular; tall cell; thyroid cancer

Indexed keywords

B RAF KINASE;

CENTRAL COMPARTMENT NECK DISSECTION; GENE; GENE MUTATION; HEAD AND NECK SURGERY; HISTOPATHOLOGY; HUMAN; LYMPHADENECTOMY; META ANALYSIS; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TUMOR VOLUME;

CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; HUMANS; PROGNOSIS; SCLEROSIS; THYROID NEOPLASMS;

EID: 79959235101     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21494     Document Type: Review

References (38)

1. Rosai J, Saxén EA, Woolner L,. Undifferentiated and poorly differentiated carcinoma. Semin Diagn Pathol 1985; 2: 123-136.
2. Carling T, Ocal IT, Udelsman R,. Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer? World J Surg 2007; 31: 916-923. (Pubitemid 46716778)
3. Volante M, Collini P, Nikiforov YE, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 2007; 31: 1256-1264. (Pubitemid 47207131)
4. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010. pp 87-96.
5. Cady B, Rossi R,. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988; 104: 947-953. (Pubitemid 19011971)
6. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS,. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993; 114: 1050-1057; discussion 1057-1058.
7. Hawk WA, Hazard JB,. The many appearances of papillary carcinoma of the thyroid. Cleve Clin Q 1976; 43: 207-215.
8. DeLellis RA, Lloyd RV, Heitz PU, Eng C,. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004.
9. Muzaffar M, Nigar E, Mushtaq S, Mamoon N,. The morphological variants of papillary carcinoma of the thyroid: a clinico-pathological study-AFIP experience. Armed Forces Institute of Pathology. J Pak Med Assoc 1998; 48: 133-137. (Pubitemid 128710786)
10. Pilotti S, Collini P, Manzari A, Marubini E, Rilke F,. Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns? Semin Diagn Pathol 1995; 12: 249-255.
11. Urano M, Kiriyama Y, Takakuwa Y, Kuroda M,. Tall cell variant of papillary thyroid carcinoma: its characteristic features demonstrated by fine-needle aspiration cytology and immunohistochemical study. Diagn Cytopathol 2009; 37: 732-737.
12. Ostrowski ML, Merino MJ,. Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid. Am J Surg Pathol 1996; 20: 964-974. (Pubitemid 26250636)
13. Sywak M, Pasieka JL, Ogilvie T,. A review of thyroid cancer with intermediate differentiation. J Surg Oncol 2004; 86: 44-54. (Pubitemid 38490100)
14. Machens A, Holzhausen H, Lautenschläger C, Dralle H,. The tall-cell variant of papillary thyroid carcinoma: a multivariate analysis of clinical risk factors. Langenbecks Arch Surg 2004; 389: 278-282. (Pubitemid 39128540)
15. Michels JJ, Jacques M, Henry-Amar M, Bardet S,. Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Hum Pathol 2007; 38: 212-219. (Pubitemid 46096555)
16. Leung AK, Chow SM, Law SC,. Clinical features and outcome of the tall cell variant of papillary thyroid carcinoma. Laryngoscope 2008; 118: 32-38.
17. Ghossein R, LiVolsi VA,. Papillary thyroid carcinoma tall cell variant. Thyroid 2008; 18: 1179-1181.
18. Ito Y, Hirokawa M, Uruno T, et al. Prevalence and biological behaviour of variants of papillary thyroid carcinoma: experience at a single institute. Pathology 2008; 40: 617-622.
19. Xing M,. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 2007; 28: 742-762. (Pubitemid 350294294)
20. Sheu SY, Grabellus F, Schwertheim S, Handke S, Worm K, Schmid KW,. Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma. Horm Metab Res 2009; 41: 482-487.
21. Frasca F, Nucera C, Pellegriti G, et al. BRAF(V600E) mutation and the biology of papillary thyroid cancer. Endocr Relat Cancer 2008; 15: 191-205. (Pubitemid 351449739)
22. Evans HL,. Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma. Am J Clin Pathol 1986; 85: 77-80. (Pubitemid 16166045)
23. Wenig BM, Thompson LD, Adair CF, Shmookler B, Heffess CS,. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases. Cancer 1998; 82: 740-753. (Pubitemid 28090287)
24. Fujimoto Y, Obara T, Ito Y, Kodama T, Aiba M, Yamaguchi K,. Diffuse sclerosing variant of papillary carcinoma of the thyroid. Clinical importance, surgical treatment, and follow-up study. Cancer 1990; 66: 2306-2312.
25. Vickery AL Jr, Carcangiu ML, Johannessen JV, Sobrinho-Simoes M,. Papillary carcinoma. Semin Diagn Pathol 1985; 2: 90-100.
26. Crile G Jr, Fisher ER,. Simultaneous occurrence of thyroiditis and papillary carcinoma; report of two cases. Cancer 1953; 6: 57-62.
27. Mizukami Y, Noguchi M, Michigishi T, et al. Papillary thyroid carcinoma in Kanazawa, Japan: prognostic significance of histological subtypes. Histopathology 1992; 20: 243-250.
28. Sheu SY, Schwertheim S, Worm K, Grabellus F, Schmid KW,. Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements. Mod Pathol 2007; 20: 779-787. (Pubitemid 46933449)
29. Carcangiu ML, Bianchi S,. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Am J Surg Pathol 1989; 13: 1041-1049. (Pubitemid 20010989)
30. Albareda M, Puig-Domingo M, Wengrowicz S, et al. Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid. Thyroid 1998; 8: 385-391. (Pubitemid 28252419)
31. Falvo L, Giacomelli L, D'Andrea V, Marzullo A, Guerriero G, de Antoni E,. Prognostic importance of sclerosing variant in papillary thyroid carcinoma. Am Surg 2006; 72: 438-444. (Pubitemid 46940744)
32. Thompson LD, Wieneke JA, Heffess CS,. Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases. Endocr Pathol 2005; 16: 331-348. (Pubitemid 43787109)
33. Baverstock KF,. Thyroid cancer in children in Belarus after Chernobyl. World Health Stat Q 1993; 46: 204-208. (Pubitemid 24169002)
34. Nikiforov YE,. Radiation-induced thyroid cancer: what we have learned from Chernobyl. Endocr Pathol 2006; 17: 307-317. (Pubitemid 47012397)
35. Carcangiu ML, Zampi G, Rosai J,. Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma." Am J Surg Pathol 1984; 8: 655-668. (Pubitemid 14068779)
36. Rufini V, Salvatori M, Fadda G, et al. Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns. Cancer 2007; 110: 1209-1217. (Pubitemid 47435590)
37. Volante M, Rapa I, Gandhi M, et al. RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab 2009; 94: 4735-4741.
38. Akslen LA, LiVolsi VA,. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer 2000; 88: 1902-1908. (Pubitemid 30213001)